Effect of bradykinin on allergen induced increase in exhaled nitric oxide in asthma

Thorax

Volumn 58, Issue 10, 2003, Pages 840-845

  Ricciardolo, F L M ^a,b   Timmers, M C ^b   Sont, J K ^b   Folkerts, G ^c   Sterk, P J ^b  

^a G GASLINI INSTITUTE   (Italy)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALLERGEN; BRADYKININ; DILUENT; N(G) METHYLARGININE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR;

ADULT; AEROSOL; ALLERGIC REACTION; ANALYSIS OF VARIANCE; AREA UNDER THE CURVE; ARTICLE; ASTHMA; ATOPY; CLINICAL ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; DRUG SCREENING; DUST; ENZYME INHIBITION; EXHALATION; HUMAN; INHIBITION KINETICS; MALE; MITE; PATIENT; PRIORITY JOURNAL; PROVOCATION TEST;

ADMINISTRATION, INHALATION; ADULT; ALLERGENS; AREA UNDER CURVE; ASTHMA; BRADYKININ; CROSS-OVER STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; NITRIC OXIDE; OMEGA-N-METHYLARGININE;

EID: 0141887274     PISSN: 00406376     EISSN: None     Source Type: Journal    
DOI: 10.1136/thorax.58.10.840     Document Type: Article

References (37)

1. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1996;43:109-42.
2. Gaston B, Lobzik L, Stamler JS. Distribution of nitric oxide synthase in the lung. In: Zapol WM, Bloch KD, eds. Nitric oxide and the lung. New York: Marcel Dekker, 1997:75-86.
3. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J 1992;6:3051-64.
4. Morris SM, Billiar TR. New insights into the regulation of inducible nitric oxide synthesis. Am J Physiol 1994;266:E829-39.
5. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996;153:454-7.
6. Saleh D, Ernst P, Lim S, et al. Increased formation of the potent oxidant peroxynitrite in the airways of asthmatic patients is associated with induction of nitric oxide synthase: effect of inhaled glucocorticoid. FASEB J 1998;12:929-37.
7. Nijkamp FP, Folkerts G. Nitric oxide and bronchial reactivity. Clin Exp Allergy 1994;24:905-14.
8. Barnes PJ, Liew FY. Nitric oxide and asthmatic inflammation. Immunol Today 1995;16:128-30.
9. Gustafsson LE, Leone AM, Persson MG, et al. Endogenous nitric oxide is present in exhaled air of rabbits, guinea pigs and humans. Biochem Biophys Res Commun 1991;181:852-7.
10. Gratziou Ch, Lignos M, Dassiou M, et al. Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur Respir J 1999;14:897-901.
11. Jatakanon A, Lim S, Kharitonov SA, et al. Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma. Thorax 1998;53:91-5.
12. Yates DH, Kharitonov SA, Robbins RA, et al. Effect of a nitric oxide synthase inhibitor and a glucocorticosteroid on exhaled nitric oxide. Am J Respir Crit Care Med 1995;152:892-6.
13. Weersink EJM, Postma DS, Aalbers R, et al. Early and late asthmatic reaction after allergen challenge. Respir Med 1994;88:103-14.
14. Kharitonov SA, O'Connor BJ, Evans DJ, et al. Allergen-induced late asthmatic reactions are associated with elevation of exhaled nitric oxide. Am J Respir Crit Care Med 1995;151:1894-9.
15. Barnes PJ. Bradykinin. In: Barnes PJ, Grunstein MM, Leff AR, Woolcock AJ, eds. Asthma. New York: Lippincott-Raven, 1997:577-B4.
16. Ricciardolo FLM, Timmers MC, Geppetti P, et al. Allergen-induced impairment of bronchoprotective nitric oxide synthesis in asthma. J Allergy Clin Immunol 2001;108:198-204.
17. Kharitonov SA, Sapienza MM, Chung KF, et al. Prostaglandins mediate bradykinin-induced reduction of exhaled nitric oxide in asthma. Eur Respir J 1999;14:1023-7.
18. 2α reduce exhaled nitric oxide in normal and asthmatic subjects irrespective of airway caliber changes. Am J Respir Crit Care Med 1998;158:1374-8.
19. National Heart, Lung and Blood Institute. Expert panel record 2. Guidelines for the diagnosis and management of asthma, NIH Publication No 97-4051. Bethesda, MD: National Institutes of Health, 1997.
20. Sterk PJ, Fabbri LM, Quanjer PhH, et al. Airway responsiveness: standardized challenge testing with pharmacological, physical and sensitizing stimuli in adults. Eur Respir J 1993;6(Suppl 16):53-83.
21. American Thoracic Society. Recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children. Am J Respir Crit Care Med 1999;160:2104-17.
22. De Gouw HWFM, Marshall-Partridge SJ, van der Veen H, et al. Role of nitric oxide in the airway response to exercise in healthy and asthmatic subjects. J Appl Physiol 2001;90:586-92.
23. Gow AJ, Stamler JS. Reactions between nitric oxide and haemoglobin under physiological conditions. Nature 1998;391:169-73.
24. 2 release by intact cells expressing cyclooxygenase-2: evidence for a "two-component" model. J Pharmacol Exp Ther 1999;288:1101-6.
25. 2 negatively modulates induction of nitric oxide synthase by interleukin 1. Proc Natl Acad Sci USA 1994;91:12168-72.
26. Griscavage JM, Hobbs AJ, Ignarro LJ. Negative modulation of nitric oxide synthase by nitric oxide and nitroso compounds. Adv Pharmacol 1995;34:215-34.
27. Cook SP, Vollenweider P, Menard B, et al. Increased eNO and pulmonary iNOS expression in eNOS null mice. Eur Respir J 2003;21:770-3.
28. Perez-Sala D, Cernuda-Morollon E, Diaz-Cazorla M, et al. Posttranscriptional regulation of human iNOS by the NO/cGMP pathway. Am J Physiol 2001;280:F466-73.
29. Figini M, Ricciardolo FLM, Javdan P, et al. Evidence that epithelium-derived relaxing factor released by bradykinin in the guinea pig trachea is nitric oxide. Am J Respir Crit Care Med 1996;153:91B-23.
30. Dweik RA, Comhair SAA, Gaston B, et al. NO chemical events in the human airway during the immediate and late antigen-induced asthmatic response. Proc Natl Acad Sci USA 2001;98:2622-7.
31. De Gouw HWFM, Hendriks J, Woltman AM, et al. Exhaled nitric oxide (NO) is reduced shortly after bronchoconstriction to direct and indirect stimuli in asthma. Am J Respir Crit Care Med 1998;158:315-9.
32. Ho LP, Wood FT, Robso A, et al. The current single exhalation method of measuring exhaled nitric oxide is affected by airway calibre. Eur Respir J 2000;15:1009-13.
33. Gustafsson LE. Exhaled nitric oxide as a marker in asthma. Eur Respir J 1998;11(Suppl26):49S-52S.
34. Hamid Q, Springall DR, Riveros-Moreno V, et al. Induction of nitric oxide synthase in asthma. Lancet 1993;342:1510-3.
35. Adcock IM, Brown CR, Kwon OJ, et al. Oxidative stress induces NF-kB DNA binding and inducible NOS mRNA in human epithelial cells. Biochem Biophys Res Commun 1994;199:1518-24.
36. Hunt JF, Fang K, Malik R, et al. Endogenous airway acidification. Implications for asthma pathophysiology. Am J Respir Crit Care Med 2000;161:694-9.
37. 2-agonist inhalation and spirometry in asthma. Am J Respir Crit Care Med 1999;159:940-4.